Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Habibi-Anbouhi, Mahdi  [Clear All Filters]
2024
Dabiri H, Sadeghizadeh M, Ziaei V, Moghadasi Z, Maham A, Hajizadeh-Saffar E, Habibi-Anbouhi M. Development of an ostrich-derived single-chain variable fragment (scFv) against PTPRN extracellular domain. Sci Rep. 2024;14(1):3689.
2023
Ziaei V, Ghassempour A, Davami F, Azarian B, Behdani M, Dabiri H, Habibi-Anbouhi M. Production and characterization of a camelid single domain anti-CD22 antibody conjugated to DM1. Mol Cell Biochem. 2023.
2019
Kardoost M, Hajizadeh-Saffar E, Ghorbanian MTaghi, Ghezelayagh Z, Bagheri KPooshang, Behdani M, Habibi-Anbouhi M. Genotoxicity assessment of antiepileptic drugs (AEDs) in human embryonic stem cells. Epilepsy Res. 2019;158:106232.
2018
Baharlou R, Tajik N, Behdani M, Shokrgozar MAli, Tavana V, Kazemi-Lomedasht F, Faraji F, Habibi-Anbouhi M. An antibody fragment against human delta-like ligand-4 for inhibition of cell proliferation and neovascularization. Immunopharmacol Immunotoxicol. 2018:1-7.
Izadi Z, Hajizadeh-Saffar E, Hadjati J, Habibi-Anbouhi M, Ghanian MHossein, Sadeghi-Abandansari H, Ashtiani MKazemi, Samsonchi Z, Raoufi M, Moazenchi M, et al. Tolerance induction by surface immobilization of Jagged-1 for immunoprotection of pancreatic islets. Biomaterials. 2018;182:191-201.
2016
Moradi-Kalbolandi S, Habibi-Anbouhi M, Golkar M, Behdani M, Rezaei G, Ghazizadeh L, Abolhassani M, Shokrgozar MAli. Datasets of a novel bivalent single chain antibody constructed by overlapping oligonucleotide annealing method targeting human CD123. Data Brief. 2016;8:1137-43.
Moradi-Kalbolandi S, Davani D, Golkar M, Habibi-Anbouhi M, Abolhassani M, Shokrgozar MAli. Soluble Expression and Characterization of a New scFv Directed to Human CD123. Appl Biochem Biotechnol. 2016.
2015
Habibi-Anbouhi M, Azadmanesh K, Behdani M, Hajizadeh-Saffar E, Vahabpour R, Shokrgozar MAli. Development and Characterization of a New Antipeptide Monoclonal Antibody Directed to Human CD20 Antigen. Cancer Biother Radiopharm. 2015;30(7):310-316.